graham russell

Citée par

	Toutes	Depuis 2020
Citations	47206	6160
indice h	102	34
indice i10	385	99

1800

900

450

1350

1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025552 543 632 553 594 638 645 630 647 590 603 623 618 880 925 960 1036 1017 911 1103 1155 1266 1266 1199 1493 1712 1628 1697 1549 1477 1454 1436 1384 1302 1396 1355 1293 1065 925 125

Accès public

Tout afficher

28 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Frank H. EbetinoUniversity of Rochester, Rochester, NYAdresse e-mail validée de ur.rochester.edu
Charles McKennaProfessor of Chemistry, University of Southern CaliforniaAdresse e-mail validée de usc.edu
Zhidao XiaSwansea UniversityAdresse e-mail validée de swansea.ac.uk
G Michael BlackburnProfessor of Chemical Biology, University of SheffieldAdresse e-mail validée de sheffield.ac.uk
Shuting SunChief Scientist/Chief Executive Officer, BioVinc LLCAdresse e-mail validée de biovinc.com
G. H. NancollasUniversity at BuffaloAdresse e-mail validée de imbb.forth.gr
apperley jProfessor of Hemato-oncology, Imperial CollegeAdresse e-mail validée de imperial.ac.uk
Michael PazianasUniversity of OxfordAdresse e-mail validée de ndorms.ox.ac.uk
Graham J Kemp MA DM DSc (Oxf) FR...Professor of Metabolic and Physiological Imaging, University of LiverpoolAdresse e-mail validée de liverpool.ac.uk
Xuchen DuanHarvard UniversityAdresse e-mail validée de hsdm.harvard.edu
Adel AssiriUmm Al-Qura UniversityAdresse e-mail validée de uqu.edu.sa
Cyrus CooperSouthampton, Oxford, Mayo ClinicAdresse e-mail validée de mrc.soton.ac.uk
Roger FrancisEmeritus Professor, Newcastle UniversityAdresse e-mail validée de ncl.ac.uk
Jukka MönkkönenBiofarmasian professori, Itä-Suomen yliopistoAdresse e-mail validée de uef.fi
David M ReidUniversity of AberdeenAdresse e-mail validée de abdn.ac.uk
Anke J RoelofsSenior Lecturer, University of EdinburghAdresse e-mail validée de ed.ac.uk
Anna Challaassociate professor of medicine, Univ of IoanninaAdresse e-mail validée de uoi.gr
Roland BaronProfessor of Medicine, Harvard UniversityAdresse e-mail validée de hsdm.harvard.edu
Stefan KnappUniversity of FrankfurtAdresse e-mail validée de pharmchem.uni-frankfurt.de
Bo AbrahamsenHolbæk Hospital and University of Southern DenmarkAdresse e-mail validée de physician.dk

Suivre

graham russell

oxford university

Adresse e-mail validée de ndorms.ox.ac.uk

bone


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Bisphosphonates: from the laboratory to the clinic and back again RGG Russell, MJ Rogers Bone 25 (1), 97-106, 1999	2230*	1999
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy RGG Russell, NB Watts, FH Ebetino, MJ Rogers Osteoporosis international 19, 733-759, 2008	1838	2008
Nitrogen‐containing bisphosphonates inhibit the mevalonate pathway and prevent post‐translational prenylation of GTP‐binding proteins, including Ras SP Luckman, DE Hughes, FP Coxon, RGG Russell, MJ Dr. Rogers Journal of bone and mineral research 13 (4), 581-589, 1998	1580	1998
Bisphosphonates: the first 40 years RGG Russell Bone 49 (1), 2-19, 2011	1443	2011
An interleukin 1 like factor stimulates bone resorption in vitro M Gowen, DD Wood, EJ Ihrie, MKB McGuire, RGG Russell Nature 306 (5941), 378-380, 1983	1272	1983
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite GH Nancollas, R Tang, RJ Phipps, Z Henneman, S Gulde, W Wu, ... Bone 38 (5), 617-627, 2006	1129	2006
Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo H Fleisch, R Graham, G Russell, MD Francis Science 165 (3899), 1262-1264, 1969	1028	1969
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation … JE Fisher, MJ Rogers, JM Halasy, SP Luckman, DE Hughes, ... Proceedings of the National Academy of Sciences 96 (1), 133-138, 1999	945	1999
Denosumab and bisphosphonates: different mechanisms of action and effects R Baron, S Ferrari, RGG Russell Bone 48 (4), 677-692, 2011	891	2011
Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo MD Francis, R Graham, G Russell, H Fleisch Science 165 (3899), 1264-1266, 1969	787	1969
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. JM Dayer, SM Krane, RG Russell, DR Robinson Proceedings of the National Academy of Sciences 73 (3), 945-949, 1976	757	1976
Bisphosphonates: mode of action and pharmacology RGG Russell Pediatrics 119 (Supplement_2), S150-S162, 2007	703	2007
Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis H Fleisch, RGG Russell, F Straumann Nature 212 (5065), 901-903, 1966	694	1966
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs KL Kavanagh, K Guo, JE Dunford, X Wu, S Knapp, FH Ebetino, ... Proceedings of the National Academy of Sciences 103 (20), 7829-7834, 2006	675	2006
Production of osteocalcin by human bone cells in vitro. Effects of 1, 25 (OH) 2D3, 24, 25 (OH) 2D3, parathyroid hormone, and glucocorticoids JN Beresford, JA Gallagher, JW Poser, RGG Russell Metabolic Bone Disease and Related Research 5 (5), 229-234, 1984	629	1984
Clodronate and liposome‐encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′‐(β, γ‐dichloromethylene) triphosphate, by mammalian cells in vitro JC Frith, J Mönkkönen, GM Blackburn, RGG Russell, MJ Rogers Journal of Bone and Mineral Research 12 (9), 1358-1367, 1997	628	1997
Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl₂MDP) on the calcification and resorption of cartilage and bone in … R Schenk, WA Merz, R Mühlbauer, RGG Russell, H Fleisch Calcified tissue research 11, 196-214, 1973	544	1973
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity CM Shipman, MJ Rogers, JF Apperley, RGG Russell, PI Croucher British journal of haematology 98 (3), 665-672, 1997	531	1997
The relationship between the chemistry and biological activity of the bisphosphonates FH Ebetino, AML Hogan, S Sun, MK Tsoumpra, X Duan, JT Triffitt, ... Bone 49 (1), 20-33, 2011	494	2011
Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. DE Hughes, BR MacDonald, RG Russell, M Gowen The Journal of clinical investigation 83 (6), 1930-1935, 1989	492	1989

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs